# TCTN (NCT02455141)

> Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02455141
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Shanghai Jiao Tong University School of Medicine
- Conditions: Breast Neoplasm
- Interventions: Epirubicin plus Cyclophosphamide; Taxanes; Taxanes plus Carboplatin
- Enrollment: 786
- Primary outcome: Disease-free survival

## Indexed commentary on TCTN so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 11
- YouTube: 2
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=tctn-nct02455141

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02455141", "email": "<work email>"}; the inbox owner confirms by the emailed link.